USHealthcare

Solventum Corp. (SOLV)

US · Healthcare · Medical Instruments & Supplies

$87.94-0.15%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$2.01B
Revenue YoY
-3.0%
Net profit
$13.0M
Profit YoY
-90.5%
EPS
$1.48
EPS estimate
$1.35
Net margin
0.6%

EPS came in at 1.48 against a street estimate of 1.35 — a beat of 9.6%.

Key statistics

Market cap
$14.80B
P/E
10.5
Forward P/E
13.0
P/B
2.98
Book value
$28.64
EPS (TTM)
$8.17
52-week high
$88.65
52-week low
$62.38
50-day MA
$78.37
200-day MA
$75.26
Beta
0.72

Analyst view

Analysts rate Solventum Corp. a hold (3 buy, 8 hold, 1 sell out of 12) with an average price target of $84.69.

Shareholding

Insiders
15.07%
Institutions
76.11%

Largest institutional holders

FundStake
Independent Franchise Partners LLP9.09%
BlackRock Inc6.05%
Vanguard Capital Management, LLC5.54%
Trian Fund Management LP4.76%
State Street Corp3.70%
Vanguard Portfolio Management, LLC3.69%
Davis Selected Advisers3.66%
Geode Capital Management, LLC2.74%

Recent filings & reports

DocumentDate
Board / officer change · Q3 20262026-07-20
Company announcement · Q2 20262026-06-05
Board / officer change · Q2 20262026-05-27
Shareholder vote results · Q2 20262026-05-20
Quarterly report · Q1 20262026-05-05
Proxy statement · Q4 20252026-03-27
Annual report FY20252026-02-27
Quarterly report · Q3 20252025-11-06

Readable in the app.

Deals & corporate news

AnnouncementDate
Fourth-quarter 2025 results reported and 2026 full-year financial guidance introduced
Solventum Corporation issued an 8-K filing on February 26, 2026, to disclose its fourth-quarter 2025 financial results and provide guidance for full-year 2026. The filing itself contains no
2026-02-26
Completed sale of purification and filtration business to Thermo Fisher
Solventum Corporation completed the sale of its purification and filtration business to Thermo Fisher Scientific on September 1, 2025, for approximately $4.0 billion in cash. The company exc
2025-09-02
Amended asset sale agreement reduces transaction value to $4.0 billion
Solventum Corporation is selling its purification and filtration business to Thermo Fisher Scientific. The deal was amended on June 25, 2025, with the sale price reduced from $4.10 billion t
2025-08-13

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Solventum Corp. — free to start.

Google PlayApp Store

Other Healthcare companies

Data updated 2026-08-05.